Navigation Links
Cordex Pharma Presents 'New Frontiers in Cardiovascular Medicines' on January 29
Date:1/23/2009

forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Cordex intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. All statements in this release regarding the future outlook related to Cordex are forward-looking statements, including, but not limited to, the statements regarding ATPace's expected entry into a pivotal Phase 3 clinical trial for the treatment of paroxysmal supraventricular tachycardia and the anticipated results of the trial, CDP-1050's expected commencement of a Phase 2 safety clinical trial in heart failure patients. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Such risks include the risk that the clinical trial for approval of ATPace and the Phase 2 clinical trial for our CDP-1050 investigational drug may not be successful, that our preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease may not be successful, and that our technology may not lead to expected results including the development or the successful commercialization of technologies relating to the use of ATP or nitric oxide. Additional uncertainties and risks are described in Cordex's most recently filed SEC documents, such as its most recent annual report on Form
'/>"/>
SOURCE Cordex Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Axikin Pharmaceuticals Spins out of Actimis
2. Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences
3. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
4. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
5. Cracking the Code: Exclusive Conference to Reveal Secrets of Chinese Pharmaceutical Industry
6. Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
7. Cumberland Pharmaceuticals Appoints Lee Product Director
8. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
9. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
10. Keryx Biopharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the ... Phase 3 study of Zerenex (ferric citrate), the Company,s ... of hyperphosphatemia in patients with end-stage renal disease (ESRD) ... delivery with FErric CiTrate in EsrD) was published online ... of Nephrology ( JASN ). , ...
(Date:7/24/2014)... July 24, 2014  Now available is a stem ... Rehealth Regenerative Therapies , located in Guadalajara, ... active people a new health option: stem cell ... age, countless patients suffer from joint and muscle injuries ... muscle tears, torn rotator cuff, tennis elbow, and knee ...
(Date:7/24/2014)... sophisticated equipment, trained personnel, and detection dogs to ... attacks. A revolutionary new electronic chip with nano-sized ... much easier. , The groundbreaking nanotechnology-inspired sensor, devised ... ,s School of Chemistry and Center for Nanoscience ... Tracense, picks up the scent of explosives molecules ...
(Date:7/24/2014)... Professor of Engineering at the University of Delaware, ... problems in energy engineering, environmental sustainability and electronics. ... porous rock with a well-defined, crystalline structure. At ... precisely decided that zeolites can separate molecules with ... angstrom (one-tenth of a nanometer), making them useful ...
Breaking Biology Technology:Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Nano-sized chip 'sniffs out' explosives far better than trained dogs 2University of Delaware researcher describes new approach for creating organic zeolites 2
... (Nasdaq:,VICL) today announced that the company will report financial ... opening of trading on,Thursday, May 8, and conduct a ... provide a company update at noon Eastern Time on,Thursday, ... basis to any interested,parties. The company will provide details ...
... PRINCETON, N.J., May 1 Orchid Cellmark Inc.,(Nasdaq: ... testing,services, will release its first quarter 2008 financial results ... and is hosting a,conference call and webcast to discuss ... Management will discuss financial results for the first quarter,2008 ...
... Oncothyreon Inc. (Nasdaq:,ONTY) (TSX:ONY) today announced that ... application with the U.S. Food and Drug ... for the treatment of advanced cancers. Following ... 1 clinical trial of PX-866., "PX-866 ...
Cached Biology Technology:Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results 2Orchid Cellmark to Announce First Quarter 2008 Financial Results on May 8, 2008 2Oncothyreon files investigational new drug application for PX-866 oncology compound 2Oncothyreon files investigational new drug application for PX-866 oncology compound 3
(Date:7/24/2014)... June 24, 2014 Some sticky research out of ... against a certain species of toxic grass fungus: moose ... month,s Biology Letters , "Ungulate saliva inhibits a ... applied to red fescue grass (which hosts a fungus ... in slower fungus growth and less toxicity. , "Plants ...
(Date:7/24/2014)... molecules, which have similar counterparts in humans, affect the ... nerve signals into the hippocampus, an area of the ... and the creation of memories. The results of the ... . , Brain function depends on the active communication ... neurons are woven together into a dense network where ...
(Date:7/24/2014)... yearlong study funded by the New Jersey Recovery Fund ... School of Planning and Public Policy at Rutgers University ... are skeptical about the likelihood of community-based rebuilding solutions. ... percent indicated they were "pessimistic" or "very pessimistic" that ... would be rebuilt better than they were before the ...
Breaking Biology News(10 mins):Moose drool inhibits growth of toxic fungus: York U research 2A protein couple controls flow of information into the brain's memory center 2A protein couple controls flow of information into the brain's memory center 3A protein couple controls flow of information into the brain's memory center 4Rutgers study explores attitudes, preferences toward post-Sandy rebuilding 2
... A series of novel imaging agents could light up ... turn deadly and signal their transition to aggressive ... cyclooxygenase-2 (COX-2) could have broad applications for detecting ... more aggressive growth, and defining tumor margins during surgical ...
... of researchers, scientists now have a more complete understanding ... the red blood cell. Led by University of ... team developed a model that could lead to breakthroughs ... malaria and sickle-cell disease. The group published its findings ...
... one of the largest fresh-water floods in Earth,s history happened ... Alaska that is now occupied in part by the city ... The event was one of at least four "megafloods" ... The lake covered more than 3,500 square miles in the ...
Cached Biology News:Fluorescent compounds make tumors glow 2Fluorescent compounds make tumors glow 3New microscopy technique reveals mechanics of blood cell membranes 2New microscopy technique reveals mechanics of blood cell membranes 3Research shows part of Alaska inundated by ancient megafloods 2Research shows part of Alaska inundated by ancient megafloods 3
dithiothreitol (DTT) Reactive Dyes and Chemicals Thiol-Reactive Dyes, Haptens and Quenchers Reducing Agents...
GRADIENT MAKER, 30 ML, 1 EA. Category: Protein Vertical Instruments....
Recombinant Rat Leptin, CF...
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
Biology Products: